Specialty Pharmacy

Deborah Michaelson, MS, RPh, vice president of Operations at Ardon Health, discusses how pharmacies can help patients overcome the cost of high co-pays to maintain specialty drug adherence.

Top news of the day from across the health care landscape.

Top news of the week in oncology and cancer drug development.

Newly developed framework offers a common ground for specialty pharmacy stakeholders.

Sovaldi plus Harvoni approved to treat HCV in children ages 12 to 17.

Dalfampridine is the only FDA-approved drug to aid walking in patients with MS.

Pharmacy benefit manager takes CVS Health’s role in providing specialty drug management for Federal Employee Program.

Small molecule inhibition of PRMT1 may be an effective therapeutic strategy in pancreatic cancer.

Technique will help scientists develop an effective HIV vaccine.

Patients with MS have a high incidence of calcium phosphate stones and struvite stones, study finds.

Top 5 most read articles this week from Specialty Pharmacy Times.

Top news of the day from across the health care landscape.

Amgen’s 2017 Trends in Biosimilars report examines commercialization and distribution issues in the biosimilar space.

Legal challenges, drug shortages, and regulatory issues create hurdles for biosimilars in the US market.

Genetic variants influences the risk of MS and other autoimmune disorders.

Genetic factors can be assessed to determine the risk of developing glioma, including glioblastoma and non-glioblastoma.

Use of either surgery resulted in equivalent disease-free survival and no difference in overall survival.

Exposure to BPA observed to increase signaling that caused cancer growth.

Sheila Arquette, RPh, director of Pharmacy Services at Independent Health, discusses the impact of prior authorizations on specialty pharmacy.

Top news of the day from across the health care landscape.

The dream of an HIV cure will only be realized if all 35 million people who are living with the virus adhere to treatment.

Strategic partnership will advance the use of data in value-based care.

Poorer health outcomes found in perinatally HIV-infected youth.

Variants of the IL7R and DDX39B genes may lead to increased risk of multiple sclerosis.

Behavioral treatments may help reduce severity of symptoms for conditions such as Crohn’s disease.

Biovica’s DiviTum assay offers noninvasive tool to monitor efficacy of CDK4/6 inhibitors.

Countries where high risk populations face punitive laws do not have access to critical HIV prevention services.

Top news of the day from across the health care landscape.